212 related articles for article (PubMed ID: 17922561)
1. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.
Yassen A; Olofsen E; Romberg R; Sarton E; Teppema L; Danhof M; Dahan A
Clin Pharmacol Ther; 2007 Jan; 81(1):50-8. PubMed ID: 17185999
[TBL] [Abstract][Full Text] [Related]
3. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study.
Olofsen E; van Dorp E; Teppema L; Aarts L; Smith TW; Dahan A; Sarton E
Anesthesiology; 2010 Jun; 112(6):1417-27. PubMed ID: 20461002
[TBL] [Abstract][Full Text] [Related]
4. Opioid-induced respiratory effects: new data on buprenorphine.
Dahan A
Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
[TBL] [Abstract][Full Text] [Related]
5. Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine.
Yassen A; Olofsen E; Kan J; Dahan A; Danhof M
Clin Pharmacokinet; 2007; 46(5):433-47. PubMed ID: 17465641
[TBL] [Abstract][Full Text] [Related]
6. Naloxone reversal of buprenorphine-induced respiratory depression.
van Dorp E; Yassen A; Sarton E; Romberg R; Olofsen E; Teppema L; Danhof M; Dahan A
Anesthesiology; 2006 Jul; 105(1):51-7. PubMed ID: 16809994
[TBL] [Abstract][Full Text] [Related]
7. Non-analgesic effects of opioids: opioid-induced respiratory depression.
Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
Dahan A; Aarts L; Smith TW
Anesthesiology; 2010 Jan; 112(1):226-38. PubMed ID: 20010421
[TBL] [Abstract][Full Text] [Related]
9. Editor's Highlight: Neurorespiratory Effects of Buprenorphine and Ethanol in Combination: A Mechanistic Study of Drug-Drug Interactions in the Rat.
Cohier C; Chevillard L; Salle S; Risède P; Roussel O; Mégarbane B
Toxicol Sci; 2017 Feb; 155(2):389-399. PubMed ID: 27803387
[TBL] [Abstract][Full Text] [Related]
10. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.
Middleton LS; Nuzzo PA; Lofwall MR; Moody DE; Walsh SL
Addiction; 2011 Aug; 106(8):1460-73. PubMed ID: 21395892
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats.
Yassen A; Kan J; Olofsen E; Suidgeest E; Dahan A; Danhof M
J Pharmacol Exp Ther; 2006 Nov; 319(2):682-92. PubMed ID: 16855177
[TBL] [Abstract][Full Text] [Related]
12. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers.
Yassen A; Olofsen E; Romberg R; Sarton E; Danhof M; Dahan A
Anesthesiology; 2006 Jun; 104(6):1232-42. PubMed ID: 16732095
[TBL] [Abstract][Full Text] [Related]
13. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal.
Algera MH; Kamp J; van der Schrier R; van Velzen M; Niesters M; Aarts L; Dahan A; Olofsen E
Br J Anaesth; 2019 Jun; 122(6):e168-e179. PubMed ID: 30915997
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
Zamani N; Hassanian-Moghaddam H
Ann Emerg Med; 2017 Jun; 69(6):737-739. PubMed ID: 28237362
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
Sekar V; Tomaka F; Lefebvre E; De Pauw M; Vangeneugden T; van den Brink W; Hoetelmans R
J Clin Pharmacol; 2011 Feb; 51(2):271-8. PubMed ID: 20421512
[No Abstract] [Full Text] [Related]
17. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
[TBL] [Abstract][Full Text] [Related]
18. The effect of a low-dose naloxone infusion on the incidence of respiratory depression after intrathecal morphine administration for major open hepatobiliary surgery: a randomised controlled trial.
Cosgrave D; Vencken S; Galligan M; McGuinness S; Soukhin E; McMullan V; Nair S; Puttappa A; Boylan J; Hussain R; Conlon N; Doran P; Nichol A
Anaesthesia; 2020 Jun; 75(6):747-755. PubMed ID: 31792949
[TBL] [Abstract][Full Text] [Related]
19. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Zamani N; Buckley NA; Hassanian-Moghaddam H
Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
